Articles with public access mandates - Luca SchifanellaLearn more
Available somewhere: 22
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
M Vaccari, SN Gordon, S Fourati, L Schifanella, NPM Liyanage, ...
Nature medicine 22 (7), 762-770, 2016
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition
M Vaccari, S Fourati, SN Gordon, DR Brown, M Bissa, L Schifanella, ...
Nature medicine 24 (6), 847-856, 2018
Mandates: Bill & Melinda Gates Foundation, US Department of Defense, US National …
Cutting edge: mouse SARS-CoV-2 epitope reveals infection and vaccine-elicited CD8 T cell responses
V Joag, S Wijeyesinghe, JM Stolley, CF Quarnstrom, T Dileepan, ...
The Journal of Immunology 206 (5), 931-935, 2021
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Regulatory and helper follicular T cells and antibody avidity to simian immunodeficiency virus glycoprotein 120
MJ Blackburn, M Zhong-Min, F Caccuri, K McKinnon, L Schifanella, ...
The Journal of Immunology 195 (7), 3227-3236, 2015
Mandates: US National Institutes of Health
Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity
C Martino, BP Kellman, DR Sandoval, TM Clausen, CA Marotz, SJ Song, ...
BioRxiv, 2020.08. 17.238444, 2020
Mandates: US National Science Foundation, US National Institutes of Health, Academy of …
Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis
AT Gustin, AR Thurman, N Chandra, L Schifanella, M Alcaide, ...
American journal of obstetrics and gynecology 226 (2), 225. e1-225. e15, 2022
Mandates: US National Institutes of Health, US Agency for International Development
Boosting of ALVAC-SIV vaccine-primed macaques with the CD4-SIVgp120 fusion protein elicits antibodies to V2 associated with a decreased risk of SIVmac251 acquisition
SN Gordon, NPM Liyanage, MN Doster, M Vaccari, ...
The Journal of Immunology 197 (7), 2726-2737, 2016
Mandates: US National Institutes of Health
Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism
RK Cheu, AT Gustin, C Lee, L Schifanella, CJ Miller, A Ha, C Kim, ...
PLoS pathogens 16 (12), e1009024, 2020
Mandates: US National Institutes of Health
Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac251 infection of macaques
NPM Liyanage, SN Gordon, MN Doster, P Pegu, M Vaccari, N Shukur, ...
Virology 450, 359-368, 2014
Mandates: US National Institutes of Health
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
L Schifanella, SW Barnett, M Bissa, V Galli, MN Doster, M Vaccari, ...
PLoS pathogens 15 (12), e1008121, 2019
Mandates: Swiss National Science Foundation, US Department of Defense, US National …
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates
IS de Castro, G Gorini, R Mason, J Gorman, M Bissa, MA Rahman, ...
Iscience 24 (2), 2021
Mandates: US Department of Defense, US National Institutes of Health
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition
G Gorini, S Fourati, M Vaccari, MA Rahman, SN Gordon, DR Brown, ...
PLoS pathogens 16 (3), e1008377, 2020
Mandates: Bill & Melinda Gates Foundation, US Department of Defense, US National …
Myeloid cell crosstalk regulates the efficacy of the DNA/ALVAC/gp120 HIV vaccine candidate
M Vaccari, S Fourati, DR Brown, I Silva de Castro, M Bissa, L Schifanella, ...
Frontiers in immunology 10, 1072, 2019
Mandates: Bill & Melinda Gates Foundation, US Department of Defense, US National …
The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis
L Schifanella, J Anderson, G Wieking, PJ Southern, S Antinori, M Galli, ...
The Journal of Infectious Diseases 227 (11), 1245-1254, 2023
Mandates: US National Institutes of Health
Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women
A Gustin, R Cromarty, L Schifanella, NR Klatt
Seminars in immunology 51, 101482, 2021
Mandates: US National Institutes of Health
HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC
M Bissa, S Kim, V Galli, S Fourati, S Sarkis, A Arakelyan, IS de Castro, ...
Nature communications 14 (1), 575, 2023
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Probiotic supplementation reduces inflammatory profiles but does not prevent oral immune perturbations during SIV infection
R Jones, K Kroll, C Broedlow, L Schifanella, S Smith, B Hueber, SV Shah, ...
Scientific reports 11 (1), 14507, 2021
Mandates: US National Institutes of Health
Expression of CD40L by the ALVAC-simian immunodeficiency virus vector abrogates T cell responses in macaques
I Silva de Castro, SN Gordon, J Liu, M Bissa, K McKinnon, HV Trinh, ...
Journal of virology 94 (6), 10.1128/jvi. 01933-19, 2020
Mandates: Swiss National Science Foundation, Bill & Melinda Gates Foundation, US …
Mission, organization, and future direction of the serological sciences network for COVID-19 (SeroNet) epidemiologic cohort studies
JC Figueiredo, FR Hirsch, LH Kushi, WN Nembhard, JM Crawford, ...
Open forum infectious diseases 9 (6), ofac171, 2022
Mandates: US National Institutes of Health
Altered innate immunity and damaged epithelial integrity in vaginal microbial dysbiosis
RK Cheu, A Mohammadi, L Schifanella, C Broedlow, CB Driscoll, ...
Frontiers in Reproductive Health 4, 876729, 2022
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program